NYSE:HYH - Halyard Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$57.21
Today's Range$56.93 - $57.91
52-Week Range$38.22 - $61.52
Volume886,271 shs
Average Volume438,537 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Halyard Health, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. Halyard Health, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Receive HYH News and Ratings via Email

Sign-up to receive the latest news and ratings for HYH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone678-425-9273

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees13,000
OptionableOptionable

Halyard Health (NYSE:HYH) Frequently Asked Questions

What is Halyard Health's stock symbol?

Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."

How were Halyard Health's earnings last quarter?

Halyard Health (NYSE:HYH) announced its quarterly earnings results on Wednesday, November, 1st. The medical instruments supplier reported $0.60 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.47 by $0.13. The medical instruments supplier had revenue of $401.40 million for the quarter, compared to the consensus estimate of $394.54 million. The company's quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.48 earnings per share. View Halyard Health's Earnings History.

What price target have analysts set for HYH?

4 equities research analysts have issued 1-year target prices for Halyard Health's stock. Their predictions range from $50.00 to $67.00. On average, they anticipate Halyard Health's share price to reach $59.25 in the next twelve months. View Analyst Price Targets for Halyard Health.

What is the consensus analysts' recommendation for Halyard Health?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Halyard Health in the last year. There are currently 1 sell rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Halyard Health.

Has Halyard Health been receiving favorable news coverage?

Headlines about HYH stock have trended neutral this week, according to InfoTrie. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Halyard Health earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned media headlines about the medical instruments supplier a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an effect on the stock's share price in the next several days.

Who are some of Halyard Health's key competitors?

Who are Halyard Health's key executives?

Halyard Health's management team includes the folowing people:
  • Mr. Steven E. Voskuil, Sr. VP & CFO (Age 50)
  • Mr. John W. Wesley, Sr. VP & Gen. Counsel (Age 59)
  • Ms. Rhonda D. Gibby, Sr. VP & Chief HR Officer (Age 50)
  • Mr. Joseph F. Woody, CEO & Director (Age 52)
  • Mr. Renato Negro, VP, Controller & Chief Accounting Officer

How do I buy shares of Halyard Health?

Shares of HYH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Halyard Health's official website?

The official website for Halyard Health is http://www.halyardhealth.com.

How can I contact Halyard Health?

Halyard Health's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier can be reached via phone at 678-425-9273 or via email at [email protected]


MarketBeat Community Rating for Halyard Health (NYSE HYH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  227 (Vote Outperform)
Underperform Votes:  235 (Vote Underperform)
Total Votes:  462
MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe HYH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HYH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel